Tyra Biosciences, Inc. · NASDAQ:TYRA

Dapice Joshua J. reported a 5.60% stake in Tyra Biosciences, Inc. (Schedule 13G)

Event Feb 12, 2026 · Filed Feb 20, 2026

Dapice Joshua J. reported a 5.60% stake in Tyra Biosciences, Inc., 2,984,818 shares, as a passive investor on Feb 12, 2026. Filed Feb 20, 2026 (Schedule 13G).

Stake
5.60%
Shares
2,984,818
Intent
Passive
What changed
Crossed above 5%
Filed together
26 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.90%505,122
Farallon Capital Institutional Partners, L.P.1.20%650,679
Farallon Capital Institutional Partners II, L.P.0.20%120,651
Farallon Capital Institutional Partners III, L.P.0.20%94,197
Four Crossings Institutional Partners V, L.P.0.20%120,497
Farallon Capital Offshore Investors II, L.P.2.40%1,272,095
Farallon Capital (AM) Investors, L.P.0.10%65,624
Farallon Capital F5 Master I, L.P.0.30%155,953
Farallon Partners, L.L.C.5.30%2,828,865
Farallon Institutional (GP) V, L.L.C.0.20%120,497
Farallon F5 (GP), L.L.C.0.30%155,953
Dapice Joshua J.5.60%2,984,818
Dreyfuss, Philip D.5.60%2,984,818
Dunn Hannah E.5.60%2,984,818
Gehani, Varun N.5.60%2,984,818
Giauque, Nicolas5.60%2,984,818
Husen, Avner A.5.60%2,984,818
Kim, David T.5.60%2,984,818
Linn, Michael G.5.60%2,984,818
Luo Patrick (Cheng)5.60%2,984,818
Roberts, Jr., Thomas G.5.60%2,984,818
Saito Edric C.5.60%2,984,818
Short Daniel S.5.60%2,984,818
Spokes, Andrew J. M.5.60%2,984,818
Warren, John R.5.60%2,984,818
Wehrly, Mark C.5.60%2,984,818

Source

View original at SEC

Related